Skip to main content
. 2020 Jul 5;25(9):1098–1109. doi: 10.1111/tmi.13450

Table 5.

Most common adverse events (>5%) among those who completed treatment

Total (n = 158)
Asthenia 19 (12.0%)
Headache 18 (11.4%)
Dizziness 14 (8.9%)
Fatigue 9 (5.7%)
Insomnia 9 (5.7%)
Flu symptoms 9 (5.7%)
Cough 9 (5.7%)
Back pain 9 (5.7%)
Cramp 9 (5.7%)
Epigastric pain 8 (5.1%)
Malaria 8 (5.1%)